M7824 Immuno-oncology Drug Study Data
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Future Of Biliary Cancer Treatment
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
ALTA-1L Trial CNS Efficacy
Sanjay Popat, M.D., of The Royal Marsden Hospital Discusses ALTA-1L Trial CNS Efficacy. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
PSMA-617 Study
Scott Tagawa, M.D., of Weill Cornell Medicine discusses PSMA-617 Study. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Availability Of PSMA-617 Radionuclide Therapy
Scott Tagawa, M.D., Of Weill Cornell Medicine discusses Availability Of PSMA-617 Radionuclide Therapy. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Whats on The Horizon For Bayer Pharmaceuticals
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Whats on The Horizon For Bayer Pharmaceuticals. At ESMO Oncology Conference - Munich, Germany On Oct...
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
The Future Of Treating Glioblastoma
David Peereboom, M.D., Cleveland Clinic Discusses The Future Of Treating Glioblastoma. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 11/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Repeal, Replace, Repeat
Wondering what’s going on with repeal and replace (and repeat)? Listen to emergency medicine policy expert Cedric Dark, MD, the founder and executive editor of PolicyPrescriptions.org, talk about how politics have affected health care in this podcast from the 2018 Policy Prescriptions Symposium. Visit http://www.policyprescriptions.org/policyrx18/ for more information about the conference and the organization. (Source: Emergency Medicine News: SoundsBites: Q&A)
Source: Emergency Medicine News: SoundsBites: Q&A - November 2, 2018 Category: Emergency Medicine Source Type: podcasts
Emerging New Agents In SCLC
Pascal Besman Chief Operating Officer at PharmaMar discusses Emerging New Agents In SCLC. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 1, 2018 Category: Cancer & Oncology Source Type: podcasts
EMBRACA Trial, Sensoring Process, QOL
Hope Rugo, M.D., University Of California San Francisco discusses EMBRACA Trial, Sensoring Process, QOL. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2018 Category: Cancer & Oncology Source Type: podcasts
Talazoparib First Line Treatment
Hope Rugo, M.D., University Of California San Francisco discusses Talazoparib First Line Treatment. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2018 Category: Cancer & Oncology Source Type: podcasts
IMpassion130, Solar-1 Trial Data
Hope Rugo, M.D., University Of California San Francisco discusses IMpassion130, Solar-1 Trial Data. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.<br />
Author: Cancer-News
Added: 10/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2018 Category: Cancer & Oncology Source Type: podcasts
EMBRACA Trial, FDA Approval Of Talazoparib
Hope Rugo, M.D., University Of California San Francisco discusses EMBRACA Trial, FDA Approval Of Talazoparib. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.<br />
Author: Cancer-News
Added: 10/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2018 Category: Cancer & Oncology Source Type: podcasts
